Drugs Made In America Acquisition Corp.

# Drugs Made In America Acquisition Corp.

Based in Fort Lauderdale, Florida, this entity is a special purpose acquisition company (SPAC) incorporated in 2024. The company has no significant operating business and exists as a blank-check vehicle designed to facilitate a business combination with an unidentified target company. Its stated purpose is to merge with, acquire assets from, or complete another form of business combination with one or more operating businesses.

As a pre-acquisition SPAC, the company has no established business segments, products, services, or revenue streams. The structure is typical of blank-check companies, where the operating vehicle remains dormant until shareholders approve a proposed merger or acquisition. At that point, the combined entity would operate under the business model of the acquired company.

The company operates with minimal infrastructure and employee base characteristic of SPACs in their initial phase. Geographic operations are limited to its headquarters jurisdiction, with primary activity focused on identifying and evaluating potential acquisition targets that align with the stated investment thesis. No revenue has been generated to date.